High-dose daunorubicin improved complete response rates in patients aged 60 and younger and survival in those younger than 50. Despite considerable advances during the past 20 years in the ...

Daunorubicin is used in the treatment of blood cancer (leukemia). It can be used on its own, or sometimes given together with certain other medicines as part of combination chemotherapy.